Keywords: astrazeneca, submits, snda, merrem, iv, submitted, supplemental

AstraZeneca submits sNDA for Merrem IV

Article | 09 August 2004

Print This

AstraZeneca has submitted a supplemental New Drug Application with theUS Food and Drug Administration, seeking approval for a new indication ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in